Showing 7,621 - 7,640 results of 7,685 for search 'initial detection', query time: 0.15s Refine Results
  1. 7621

    Comparison of two combined drug therapy regimens for renal damage in patients with metastatic kidney cancer after previously performed unilateral nephrectomy by K. S. Titov, M. V. Epifanova, A. A. Alimov, O. Yu. Nesterova, E. V. Shutov, S. S. Lebedev, G. M. Zapirov

    Published 2025-06-01
    “…Over the entire duration of therapy, urea in the ipilimumab + nivolumab group was 1.7 mmol/L higher (p = 0.010) than in the pembrolizumab + axitinib group with initially comparable parameters. The maximum difference in urea between the groups was observed after the 5th and 12th administration of the drugs, amounting to 2.6 mmol/l and 2.7 mmol/l, respectively (p = 0.009 and p = 0.032, respectively).Conclusion. …”
    Get full text
    Article
  2. 7622
  3. 7623

    Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors by Juan Chen, Jun-yan Liu, Fan Yang, Ting Zou, Zhan Wang, Jia-Si Liu, Lei She, Xiang-Ping Li, Zhaoqian Liu

    Published 2024-07-01
    “…Untargeted metabolomics analysis was used to identify the differential metabolites before initiating ICIs treatment and during the process that development of irAEs. …”
    Get full text
    Article
  4. 7624
  5. 7625
  6. 7626
  7. 7627

    Integrating hepatitis C testing and treatment into routine HIV care in Cameroon is feasible by Mathurin Pierre Kowo, Liza Coyer, Victor Sini, Carole Assontsa Kafack, Gabriella Yelheen Metomo, Guy S. Wafeu, Richard Njouom, Alexander Boers, Roel Coutinho, Oudou Njoya, Charles Kouanfack, the DHEPC project team

    Published 2025-02-01
    “…Among 286 sampled, 251 (87.8%) had detectable HCV RNA. Of these, 173 (68.9%) enrolled for treatment, 55 (21.9%) were eligible but not enrolled (49 lost‐to‐follow‐up, 6 denied) and 23 (9.2%) were ineligible. …”
    Get full text
    Article
  8. 7628

    A case-control study on Chlamydia psittaci pneumonia and legionella pneumonia by Ying Gao, Yuan-jie Lin, Wen-long Zhang, Jian-ming Ni, Shu-guang Han, Liang Bao

    Published 2025-06-01
    “…PurposeAtypical pathogens (Chlamydia psittaci and Legionella) are often detected by metagenomic next-generation sequencing (mNGS). …”
    Get full text
    Article
  9. 7629

    The Role of Intestinal Translocation in the Pathogenesis of Pneumonia in Acute Poisoning and the Contribution of Intestinal Lavage to Its Prevention and Resolution by V. A. Matkevich, T. T. Tkeshelashvili, A. G. Vorobyova, N. E. Stolbova, M. M. Potskhveriya, Yu. S. Goldfarb

    Published 2024-09-01
    “…Patients in the comparison groups (469) received standard therapy.   RESULTS. Initially detected: intestinal dysbiosis of II–III degree, increased permeability of the intestinal barrier — 3.8–4.9 times higher than normal, a tenfold increase in the content of endotoxin in the blood and a 6-fold increase in the leukocyte index of intoxication. …”
    Get full text
    Article
  10. 7630

    Prevalence of Staphylococcus aureus Isolated from Clinical Samples that Exhibits Inducible Clindamycin Resistance: A Cross-sectional Study by Akansha Goyal, Akansha Arya, Kajal Rajput, Sapna Chauhan

    Published 2025-04-01
    “…Identifying iMLSB resistance is crucial for effectively managing S. aureus. Aim: To detect the prevalence of inducible CLI resistance in S. aureus isolates from various clinical samples and to determine the association between methicillin resistance and inducible CLI resistance in S. aureus isolates. …”
    Get full text
    Article
  11. 7631
  12. 7632

    Analysis of molecular resistance and associated risk factors in tuberculosis by Zhenzhen Wang, Tengfei Guo, Liyang Xu, Jinwei Liu, Long Li, Junrong Jin, Qing Zhang, Tao Jiang, Zhanqin Zhao, Yun Xue

    Published 2025-02-01
    “…Abstract Background Local surveillance of molecular resistance to first-line anti-tuberculosis (TB) drugs and fluoroquinolones (FQs) was initiated in 2019, but existing reports remain limited, hindering effective TB prevention and control efforts. …”
    Get full text
    Article
  13. 7633

    The Role of Tumor Necrosis Factor and ITS Soluble Receptors in Myelosuppression Developing in B-Cell Chronic Lymphocytic Leukemia by Barilka V., Matlan V., Prymak S., Vygovska O., Shalay O.

    Published 2015-09-01
    “…In addition, any changes were detected in TNF, sTNFRI and sTNFRII concentrations in patients with thrombocytopenia. …”
    Get full text
    Article
  14. 7634

    Rifampicin-resistant tuberculosis in Fujian Province, Southeast China: a retrospective analysis of drug resistance screening and treatment outcomes, 2019–2024 by Yinfa Zhou, Zhisong Dai, Zhisong Dai, Shufang Lin, Shufang Lin, Daiquan Chen, Jian Lin, Kun Chen, Yongming Lin, Yanqin Deng, Yanqin Deng

    Published 2025-07-01
    “…Of 1,056 RR-TB patients initiated on treatment, 720 had outcome data, revealing a low success rate (58.6%) due to high loss to follow-up (31.1%) and mortality (9.3%). …”
    Get full text
    Article
  15. 7635
  16. 7636
  17. 7637

    PREDİCTİON OF THE RİSK OF LEUKEMİA DEVELOPMENT İN AGED HEALTHY POPULATİON: IMPLEMENTATİON İN THE PUBLİC HEALTH SYSTEM by Francesco Frassoni, Roberto Tedone, Emanuela Marcenaro, Giorgio Piastra, Davide Guerr

    Published 2025-07-01
    “…(Nature. 2018) these mutations are detectable many years before the clinical onset of Acute Myeloid Leukemia (AML) and are potentially linked to its subsequent evolution. …”
    Get full text
    Article
  18. 7638

    Results of asciminib therapy as part of managed access program in patients with chronic myeloid leukemia with T315I mutation by A. N. Petrova, E. G. Lomaia, E. V. Morozova, O. A. Shukhov, E. Yu. Chelysheva, Yu. Yu. Vlasova, E. A. Kuzmina, O. V. Kulemina, I. S. Nemchenko, A. V. Bykova, A. B. Sudarikov, A. V. Kokhno, A. G. Turkina

    Published 2025-05-01
    “…The therapy results of patients in initially unfavorable 2Cp / Cp ACA+ group were comparable with Cp group in terms of both survival rates and probability of achieving responses. …”
    Get full text
    Article
  19. 7639
  20. 7640

    Response to amoxicillin and perampanel in infantile Alexander disease by Susana Boronat, Eulalia Turon‐Viñas, Noel Mac Manus, Asuncion Diaz‐Gomez, Mónica Vicente, Victoria Ros‐Castelló, Alba Sierra‐Marcos

    Published 2024-12-01
    “…We describe a patient presenting with irritability starting at 2 months of age, initially attributed to gastroesophageal reflux. A ventriculoperitoneal shunt was placed at 3 months of age due to hydrocephalus secondary to aqueduct stenosis detected through an MRI scan, but the irritability persisted. …”
    Get full text
    Article